National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 156-157 [E9-31141]
Download as PDF
156
Federal Register / Vol. 75, No. 1 / Monday, January 4, 2010 / Notices
conducting quarterly performance testing
plus periodic on-site inspections of those
LAPSA-accredited laboratories was
transferred to the U.S. HHS, with the HHS’
NLCP contractor continuing to have an active
role in the performance testing and
laboratory inspection processes. Other
Canadian laboratories wishing to be
considered for the NLCP may apply directly
to the NLCP contractor just as U.S.
laboratories do.
Upon finding a Canadian laboratory to be
qualified, HHS will recommend that DOT
certify the laboratory (Federal Register, July
16, 1996) as meeting the minimum standards
of the Mandatory Guidelines published in the
Federal Register on April 13, 2004 (69 FR
19644). After receiving DOT certification, the
laboratory will be included in the monthly
list of HHS-certified laboratories and
participate in the NLCP certification
maintenance program.
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Elaine Parry,
Director, Office of Program Services,
SAMHSA.
[FR Doc. E9–30979 Filed 12–31–09; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4160–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
pwalker on DSK8KYBLC1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Studying Community Programs to Reduce
Childhood Obesity.
Date: January 29, 2010.
Time: 8 a.m. to 2 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Mark Roltsch, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7192,
Bethesda, MD 20892–7924, 301–435–0287,
roltschm@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
VerDate Nov<24>2008
17:11 Dec 31, 2009
Jkt 220001
Dated: December 28, 2009.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31138 Filed 12–31–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group, Biochemistry and Biophysics
of Membranes Study Section.
Date: January 27–28, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Nuria E. Assa-Munt, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4164,
MSC 7806, Bethesda, MD 20892. (301) 451–
1323. assamunu@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group, Enabling Bioanalytical and
Biophysical Technologies Study Section.
Date: January 28–29, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: Vonda K. Smith, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7806, Bethesda, MD 20892. 301–435–
1789. smithvo@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Conflicts: Biological Chemistry and
Macromolecular Biophysics.
Date: January 28–29, 2010.
Time: 11 a.m. to 10 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting.)
Contact Person: Donald L. Schneider, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5160,
MSC 7842, Bethesda, MD 20892. (301) 435–
1727. schneidd@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31139 Filed 12–31–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, ‘‘Autoimmunity.’’
Date: January 19, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call)
Contact Person: Priti Mehrotra, PhD, Chief,
Immunology Review Branch, Scientific
Review Program, National Institutes of
Health/NIAID, 6700B Rockledge Drive, Room
3138, Bethesda, MD 20892–7616, 301–435–
9369, pm158b@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\04JAN1.SGM
04JAN1
Federal Register / Vol. 75, No. 1 / Monday, January 4, 2010 / Notices
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, The Infant Microbiome and
Immune Maturation.
Date: January 21, 2010.
Time: 11 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call)
Contact Person: Raymond Richard Schleef,
PhD, Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892–7616, 301–451–3679,
schleefrr@niaid.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 24, 2009
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31141 Filed 12–31–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
pwalker on DSK8KYBLC1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel,
Chemosensory Clinical Research Center
Grant.
Date: January 28, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Nov<24>2008
17:11 Dec 31, 2009
Jkt 220001
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852.
(Telephone Conference Call.)
Contact Person: Sheo Singh, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
Executive Plaza South, Room 400C, 6120
Executive Blvd., Bethesda, MD 20892. 301–
496–8683. singhs@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: December 24, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–31140 Filed 12–31–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Immigration and Customs
Enforcement
Agency Information Collection
Activities: Extension of a Currently
Approved Information Collection;
Comment Request
ACTION: 30-Day Notice of Information
Collection under Review; File No.
OMB–6, Emergency Federal Law
Enforcement Assistance; OMB Control
No. 1653–0019.
The Department of Homeland
Security, U.S. Immigration and Customs
Enforcement (USICE), will be
submitting the following information
collection request for review and
clearance in accordance with the
Paperwork Reduction Act of 1995. The
information collection was previously
published in the Federal Register on
October 13, 2009, Vol. 74 No. 196
52498, allowing for a 60 day comment
period. USICE received no comments on
this Information Collection from the
public during this 60 day period.
The purpose of this notice is to allow
an additional 30 days for public
comments. Comments are encouraged
and will be accepted for thirty days
until February 3, 2010.
Written comments and suggestions
from the public and affected agencies
regarding items contained in this notice
and especially with regard to the
estimated public burden and associated
response time should be directed to the
Office of Information and Regulatory
Affairs, Office of Management and
Budget. Comments should be addressed
to OMB Desk Officer, for United States
Immigration and Customs Enforcement,
Department of Homeland Security, and
sent via electronic mail to
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
157
oira_submission@omb.eop.gov or faxed
to (202) 395–5806.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of currently approved
information collection.
(2) Title of the Form/Collection:
Emergency Federal Law Enforcement
Assistance.
(3) Agency form number, if any, and
the applicable component of the
Department of Homeland Security
sponsoring the collection: (File No.
OMB–6) U.S. Immigration and Customs
Enforcement.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: State, Local or Tribal
Government. Section 404(b) of the
Immigration and Naturalization Act
provides for the reimbursement to States
and localities for assistance provided in
meeting an immigration emergency.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: 10 responses at 30 minutes (.50
hours) per response.
(6) An estimate of the total public
burden (in hours) associated with the
collection: 300 annual burden hours.
Requests for a copy of the proposed
information collection instrument, with
instructions; or inquiries for additional
information should be requested via email to: forms.ice@dhs.gov with ‘‘IEF—
Emergency Assistance’’ in the subject
line.
E:\FR\FM\04JAN1.SGM
04JAN1
Agencies
[Federal Register Volume 75, Number 1 (Monday, January 4, 2010)]
[Notices]
[Pages 156-157]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-31141]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, ``Autoimmunity.''
Date: January 19, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone Conference Call)
Contact Person: Priti Mehrotra, PhD, Chief, Immunology Review
Branch, Scientific Review Program, National Institutes of Health/
NIAID, 6700B Rockledge Drive, Room 3138, Bethesda, MD 20892-7616,
301-435-9369, pm158b@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing
[[Page 157]]
limitations imposed by the review and funding cycle.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, The Infant Microbiome and Immune
Maturation.
Date: January 21, 2010.
Time: 11 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone Conference Call)
Contact Person: Raymond Richard Schleef, PhD, Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institutes of Health/NIAID, 6700B Rockledge
Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-3679,
schleefrr@niaid.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 24, 2009
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-31141 Filed 12-31-09; 8:45 am]
BILLING CODE 4140-01-P